Live Breaking News & Updates on Investors general

Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Spain , Neurocentre-magendie , Arthur-rouill , Daelis-farma , Vincenzo-piazza , Linkedin , Corporate-development , Twitter , Regulatory-news , Combined-general-meeting , Lafaurie-de-mondabon

Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs

United-states , Spain , Paris , France-general , France , Vincenzo-piazza , Magendie-neurocenter , Daelis-farma , Arthur-rouill , Twitter , Linkedin , Combined-general-meeting

Aelis Farma: Ordinary General Meeting of June 28, 2022: Availability of Preparatory Documents and Participation and Voting Procedures

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »),

United-states , France , French , Nicolas-merigeau , Vincenzo-piazza , Inserm-magendie-neurocentre , Daelis-farma , Albert-marquet , Inserm-transfert-initiative , Centre-broca-nouvelle-aquitaine , Neurology-of-the-french-academy-sciences , Regulatory-news

Transgene's Combined General Meeting of May 25, 2022

Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard

Milan , Lombardia , Italy , United-states , Illkirch-graffenstaden , Alsace , France , Andernach , Rheinland-pfalz , Germany , French , Lucie-larguier

Genomic Vision Announces the Approval by Its Shareholders' Meeting of All the Resolutions Supported by the Executive Board

Regulatory News: Genomic Vision(FR0011799907 GV the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, informs its

Paris , France-general , France , Bagneux , Dominique-remy-renou , Strategic-communications , Euronext , Regulatory-news , Extraordinary-shareholder-meeting , Des-meuniers , Investors-general , Genomic-vision